Abstract
This review summarises the screening methods from hepatic ultrasonography to serological biomarkers for early detection of liver cancer and focuses on evaluation of biomarkers ability. The development of novel biomarkers according to the 5-phase program defined by the Early Detection Research Network (EDRN) is also outlined in this review.
Keywords: Hepatocellular carcinoma, early cancer detection network, diagnostic imaging, serological biomarkers
Protein & Peptide Letters
Title: Biomarkers for Early Detection of Liver Cancer: Focus on Clinical Evaluation
Volume: 16 Issue: 5
Author(s): Stella Sun, Philip J.R. Day, Nikki P. Lee and John M. Luk
Affiliation:
Keywords: Hepatocellular carcinoma, early cancer detection network, diagnostic imaging, serological biomarkers
Abstract: This review summarises the screening methods from hepatic ultrasonography to serological biomarkers for early detection of liver cancer and focuses on evaluation of biomarkers ability. The development of novel biomarkers according to the 5-phase program defined by the Early Detection Research Network (EDRN) is also outlined in this review.
Export Options
About this article
Cite this article as:
Sun Stella, Day J.R. Philip, Lee P. Nikki and Luk M. John, Biomarkers for Early Detection of Liver Cancer: Focus on Clinical Evaluation, Protein & Peptide Letters 2009; 16 (5) . https://dx.doi.org/10.2174/092986609788167888
DOI https://dx.doi.org/10.2174/092986609788167888 |
Print ISSN 0929-8665 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5305 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
13-lncRNAs Signature to Improve Diagnostic and Prognostic Prediction of Hepatocellular Carcinoma
Combinatorial Chemistry & High Throughput Screening Apoptosis in Drug Response
Current Pharmacogenomics Editorial (Thematic Issue: Cytochrome P450 for Cancer Prevention and Therapy)
Anti-Cancer Agents in Medicinal Chemistry Role of the Akt Pathway in Prostate Cancer
Current Cancer Drug Targets Targeting the Ataxia Telangiectasia Mutated Protein in Cancer Therapy
Current Drug Targets Enhanced Free Radical Status of Cancer Cells Success and Failure of Prooxidant/Antioxidant Treatment
Current Signal Transduction Therapy Decreased Serum Adiponectin Level Affected Clinical Pathological Characteristics of Patients with Gastric Cancer
Current Proteomics Genes Associated with Epithelial-Mesenchymal Transition: Possible Therapeutic Targets in Ductal Pancreatic Adenocarcinoma?
Anti-Cancer Agents in Medicinal Chemistry Efficient Purification of rhG-CSF and its PEGylated Forms and Evaluation for In Vitro Activities
Protein & Peptide Letters Targeting Metabolic Enzymes in Cancer – Clinical Trials Update
Current Enzyme Inhibition Gene Therapy Using IL-12 Family Members in Infection, Auto-Immunity, and Cancer
Current Gene Therapy Patent Selections
Recent Patents on Anti-Cancer Drug Discovery Development of Peptides as Potential Drugs for Cancer Therapy
Current Pharmaceutical Design Significance of Pharmacogenetics and Pharmacogenomics Research in Current Medical Practice
Current Drug Metabolism Natural Compounds as Antagonists of Canonical Wnt/β-Catenin Signaling
Current Chemical Biology Biomolecules of Human Female Fertility - Potential Therapeutic Targets for Pharmaceutical Design
Current Pharmaceutical Design Cannabis Phenolics and their Bioactivities
Current Medicinal Chemistry Tumoral Drug Metabolism: Perspectives and Therapeutic Implications
Current Drug Metabolism The Common Mycobacterial Antigens and their Importance in the Treatment of Disease
Current Pharmaceutical Design Targeting the Perpetrator: Breast Cancer Stem Cell Therapeutics
Current Drug Targets